JUPITER, Florida — April 4, 2022 — Ascendiant Capital Markets, LLC (“Ascendiant”) announced today the filing of a $9,360,000 At-the-Market (ATM) Offering for ENDRA Life Sciences, Inc. (Nasdaq: NDRA) of Ann Arbor, Michigan, pursuant to an amendment to a prospectus supplement dated June 21, 2021. For a copy of the announcement, please click here.